Anti-Takeover Defenses and Structural Impediments

What this video covers

• Why a shareholder rights plan (poison pill) is a board control mechanism, not a permanent sale-blocker, and how the flip-in versus flip-over provisions dilute the acquirer
• What beneficial ownership means for trigger calculations, and why derivatives, options, and swaps can count toward the pill threshold even without record ownership
• How a staggered (classified) board operates as a delay mechanism, and why there is no universal two-year or two-contest rule for hostile bidders seeking board control
• What a control share acquisition statute actually restricts (voting rights, not ownership rights), and the process for restoring those voting rights
• Why a fair price statute targets only coercive two-tier tender offers, and how a uniform single-tier offer bypasses the restriction entirely
• How a business combination statute labels an acquirer as an interested stockholder, and why state-specific thresholds and delay periods are never universal
• The defeasibility cheat code for all three state-law statutes: advance board approval, and why ESOP exclusions and other carve-outs vary by jurisdiction